Role of vitamin D levels and vitamin D supplementation on bone mineral density in Klinefelter syndrome

Osteoporosis International

Volumn 26, Issue 8, 2015, Pages 2193-2202

  Ferlin, A ^a   Selice, R ^a   Di Mambro, A ^a   Ghezzi, M ^a   Di Nisio, A ^a   Caretta, N ^a   Foresta, C ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Bone mineral density; Hypogonadism; Klinefelter; Osteoporosis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIFEDIOL; ESTRADIOL; GONADOTROPIN; INSULIN; PARATHYROID HORMONE; TESTOSTERONE; VITAMIN D; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER;

ADULT; ANDROGEN THERAPY; ARTICLE; BODY MASS; BODY WEIGHT; BONE DENSITOMETRY; BONE DENSITY; BONE MASS; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTRADIOL BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; HUMAN; HYPOGONADISM; INSULIN BLOOD LEVEL; KLINEFELTER SYNDROME; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WAIST CIRCUMFERENCE; ANALOGS AND DERIVATIVES; ANTHROPOMETRY; BLOOD; COMPLICATION; DIETARY SUPPLEMENT; DRUG EFFECTS; FEMORAL NECK; HORMONE SUBSTITUTION; LUMBAR VERTEBRA; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; ANTHROPOMETRY; BIOMARKERS; BONE DENSITY; CALCIFEDIOL; DIETARY SUPPLEMENTS; FEMUR NECK; HORMONE REPLACEMENT THERAPY; HUMANS; KLINEFELTER SYNDROME; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; RETROSPECTIVE STUDIES; TESTOSTERONE; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84938971954     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-015-3136-8     Document Type: Article

References (42)

1. Lanfranco F, Kamischke A, Zitzmann M, Nieschlag E (2004) Klinefelter’s syndrome. Lancet 364:273–283
2. Klinefelter HF, Reifenstein EC, Albright F (1942) Syndrome characterized by gynecomastia, aspermatogenesis without a-Leydigism, and increased excretion of follicle-stimulating hormone. J Clin Endocrinol Metab 2:615–627
3. Campbell WA, Price WH (1981) Venous thromboembolic disease in Klinefelter’s syndrome. Clin Genet 19:275–80
4. Swerdlow AJ, Higgin CD, Schomaker MJ, Wright AF, Jacobs PA (2005) Mortality in patients with Klinefelter’s syndrome in Britain: a cohort study. J Clin Endocrinol Metab 90:6516–6522
5. Bojesen A, Gravholt CH (2011) Morbidity and mortality in Klinefelter syndrome (47XXY). Acta Paediatr 100:807–13
6. Kübler A, Schulz G, Cordes U, Beyer J, Krause U (1992) The influence of testosterone substitution on bone mineral density in patients with Klinefelter’s syndrome. Exp Clin Endocrinol 100:129–132
7. Breuil V, Euller-Ziegler L (2001) Gonadal dysgenesis and bone metabolism. Joint Bone Spine 68:26–33
8. van den Bergh JP, Hermus AR, Spruyt AI, Sweep CG, Corstens FH, Smals AG (2001) Bone mineral density and quantitative ultrasound parameters in patients with Klinefelter’s syndrome after long-term testosterone substitution. Osteoporos Int 12:55–62
9. Ferlin A, Schipilliti M, Vinanzi C, Garolla A, Di Mambro A, Selice R, Lenzi A, Foresta C (2011) Bone mass in subjects with Klinefelter syndrome: role of testosterone levels and androgen receptor gene CAG polymorphism. J Clin Endocrinol Metab 96(4):739–45
10. Luisetto G, Mastrogiacomo I, Bonanni G, Pozzan G, Botteon S, Tizian L, Galuppo P (1995) Bone mass and mineral metabolism in Klinefelter’s syndrome. Osteoporos Int 5:455–461
11. Bojesen A, Birkebæk N, Kristensen K, Heickendorff L, Mosekilde L, Christiansen JS, Gravholt CH (2011) Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone. Osteoporos Int 22:1441–50
12. Jo DG, Lee HS, Joo YM, Seo JT (2013) Effect of testosterone replacement therapy on bone mineral density in patients with Klinefelter syndrome. Yonsei Med J 54(6):1331–5
13. Foresta C, Ruzza G, Mioni R, Meneghello A, Baccichetti C (1983) Testosterone and bone loss in Klinefelter syndrome. Horm Metab Res 15:56–57
14. Horowitz M, Wishart JM, O’Loughlin PD, Morris HA, Need AG, Nordin BE (1992) Osteoporosis and Klinefelter’s syndrome. Clin Endocrinol (Oxf) 36:113–118
15. Seo JT, Lee JS, OhTH JKJ (2007) The clinical significance of bone mineral density and testosterone levels in Korean men with non mosaic Klinefelter’s syndrome. BJU Int 99:141–146
16. Wong FH, Pun KK, Wang C (1993) Loss of bone mass in patients with Klinefelter’s syndrome despite sufficient testosterone replacement. Osteoporos Int 3:3–7
17. Battault S, Whiting SJ, Peltier SL, Sadrin S, Gerber G, Maixent JM (2013) Vitamin D metabolism, functions and needs: from science to health claims. Eur J Nutr 52:429–441
18. Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477–501
19. Choudhary D, Jansson I, Stoilov I, Sarfarazi M, Schenkman JB (2005) Expression patterns of mouse and human CYP orthologs (families 1–4) during development and in different adult tissues. Arch Biochem Biophys 436:50–61
20. Blomberg Jensen M, Nielsen JE, Jørgensen A, Rajpert-De Meyts E, Kristensen DM, Jørgensen N, Skakkebaek NE, Juul A, Leffers H (2010) Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract. Hum Reprod 25:1303–11
21. Ferlin A, Selice R, Carraro U, Foresta C (2013) Testicular function and bone metabolism—beyond testosterone. Nat Rev Endocrinol 9:548–54
22. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM (2006) Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 91:1995–2010
23. Grant WB, Holick MF (2005) Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev 10:94–111
24. Leib ES, Lewiecki EM, Binkley N, Hamdy RC, International Society for Clinical Densitometry (2004) Official positions of the international society for clinical densitometry. J Clin Densitom 7:1–6
25. Ferlin A, Schipilliti M, Di Mambro A, Vinanzi C, Foresta C (2010) Osteoporosis in Klinefelter’s syndrome. Mol Hum Reprod 16:402–410
26. Romeo JH, Ybarra J (2007) Hypogonadal hypogonadism and osteoporosis in men. Nurs Clin North Am 42:87–99, vii-viii
27. Dupree K, Dobs A (2004) Osteopenia and male hypogonadism. Rev Urol 6(Suppl 6):S30–S34
28. Iitsuka Y, Bock A, Nguyen DD, Samango-Sprouse CA, Simpson JL, Bischoff FZ (2001) Evidence of skewed X-chromosome inactivation in 47,XXY and 48,XXYY Klinefelter patients. Am J Med Genet 98:25–31
29. Chamberlain NL, Driver ED, Miesfeld RL (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22:3181–3186
30. Zitzmann M, Depenbusch M, Gromoll J, Nieschlag E (2004) X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients. J Clin Endocrinol Metab 89:6208–6217
31. Overvad S, Bay K, Bojesen A, Gravholt CH (2014) Low INSL3 in Klinefelter syndrome is related to osteocalcin, testosterone treatment and body composition, as well as measures of the hypothalamic-pituitary-gonadal axis. Andrology 2:421–7
32. Foresta C, Strapazzon G, De Toni L, Perilli L, Di Mambro A, Muciaccia B, Sartori L, Selice R (2011) Bone mineral density and testicular failure: evidence for a role of vitamin D 25-hydroxylase in human testis. J Clin Endocrinol Metab 96:646–52
33. Foresta C, Selice R, Di Mambro A, Strapazzon G (2010) Testiculopathy and vitamin D insufficiency. Lancet 376:1301
34. Foresta C, Selice R, De Toni L, Di Mambro A, Carraro U, Plebani M, Garolla A (2013) Altered bone status in unilateral testicular cancer survivors: role of CYP2R1 and its luteinizing hormone-dependency. J Endocrinol Invest 36:379–84
35. Foresta C, Calogero AE, Lombardo F, Lenzi A, Ferlin A (2014) Late-onset hypogonadism—beyond testosterone. Asian J Androl. doi:10.4103/1008-682X.135985
36. Hannan MT, Litman HJ, Araujo AB, McLennan CE, McLean RR, McKinlay JB, Chen TC, Holick MFS (2008) Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men. J Clin Endocrinol Metab 93:40–6
37. Barbour KE, Zmuda JM, Horwitz MJ, Strotmeyer ES, Boudreau R, Evans RW, Ensrud KE, Gordon CL, Petit MA, Patrick AL, Cauley JA (2011) Osteoporotic fractures in men (MrOS) research group. The association of serum 25-hydroxyvitamin D with indicators of bone quality in en of Caucasian and African ancestry. Osteoporos Int 22:2475–85
38. Reid IR, Bolland MJ (2014) Skeletal and nonskeletal effects of vitamin D: is vitamin D a tonic for bone and other tissues? Osteoporos Int. May 21. [Epub ahead of print]
39. Cranney A, Horsley T, O’Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V (2007) Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) 158:1–235
40. Jones G, Hogan DB, Yendt E, Hanley DA (1996) Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis. CMAJ 155:955–61
41. Papadimitropoulos E, Wells G, Shea B, Gillespie W, Weaver B, Zytaruk N, Cranney A, Adachi J, Tugwell P, Josse R, Greenwood C, Guyatt G, Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group (2002) Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 23:560–9
42. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B (2005) Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 293:2257–64